Tuberculosis (TB) is a
serious, infectious airborne bacterial disease caused by the bacterium Mycobacterium tuberculosis, which is largely
spread by coughing.
Health authorities say
up to one-third of the world’s population are infected with TB at any point in
time with the vast majority of cases being spread throughout Africa and Asia.
TB was once the
leading cause of death in the United States. Now, due to an unexpected increase
in cases in the U.S., health authorities claim TB might be making a resurgence here.
Thankfully, clinical studies have shown antimicrobial silver to be highly effective against the TB pathogen. Here’s what you need to know…
Thankfully, clinical studies have shown antimicrobial silver to be highly effective against the TB pathogen. Here’s what you need to know…
Hi, Steve Barwick here, for The Silver Edge…
An article
in the Washington Post dated March
24, 2016 says tuberculosis (TB) cases have increased in the U.S. for the first
time in 23 years.
With a total of 9,563 cases being reported in the U.S. in 2015,
which is 157 cases over those reported the previous year, the Post claims medical experts aren’t sure
yet whether or not this increase could signal “a resurgence of one of the world’s
deadliest diseases.”
The largest increases in cases of TB appear to be in
California, Texas, Florida and New York – population centers constituting a
whopping one-third of the U.S. population.
According to the Washington Post article:
“The disease is treatable with antibiotics, but the course can be long
and complicated.
Certain
forms of the bacterium that causes TB are becoming impervious to the drugs
designed to kill them, leading to the development of multidrug-resistant strains
of infection.
… In a related report,
the CDC also called for increased awareness of the potential for active TB
among foreign-born temporary workers.”
Will Colloidal Silver
Help?
Does colloidal silver work against TB?
Some experts say it will.
Indeed, in one clinical
study researchers concluded that silver nanoparticles, “showed excellent antibacterial activities
against M. tuberculosis around 10 ppm.”
The well-known and
highly respected Dr. Gordon Pedersen wrote, in his 2014 book “A New Fighting
Chance”:
“Tuberculosis is a common and often deadly infectious disease
caused by mycobacteria…silver has destroyed tuberculosis in laboratory
studies.
By drinking two teaspoons twice daily and inhaling from a
nebulizer 30 minutes each day, you may affect the tuberculosis in both the
lungs and the bloodstream.
Tuberculosis is not easy to beat. This dosage may need to be followed for weeks or months. You should see benefits after the first dose and each repeated use.”
Tuberculosis is not easy to beat. This dosage may need to be followed for weeks or months. You should see benefits after the first dose and each repeated use.”
According to a clinical study published
in the Journal of Nanobiotechnology
in May 2012, both gold and silver nanoparticles were demonstrated to be
effective against the pathogen Bacillus
Calmette-Guerin (BCG) which is used in clinical studies as a surrogate for
the tuberculosis bacteria. The
researchers wrote:
“Diseases such as tuberculosis (TB) have
always had a large impact on human health. Bacillus Calmette-Guérin (BCG) is
used as a surrogate for TB during the development of anti-TB drugs.
…The purpose of this study was to examine
the potential of nanoparticles as anti-TB compounds by studying the interacting
mechanisms between nanoparticles and bacteria.
… We investigated effects of gold and
silver nanoparticles on BCG and Escherichia coli…The
results suggest the nanoparticles have potential applications as anti-TB
compounds… In terms of anti-TB drug development, this study suggests that nanoparticles
may represent useful candidates for therapeutics.
Colloidal silver has been used as an
antibacterial agent since ancient Greece. Unlike antibiotic drugs, bacteria
cannot easily develop resistance because silver targets multiple components in
the bacterial cell. As a result, silver is used in medical equipment coatings and
dental resin components.
In conclusion, we have demonstrated that
gold and silver nanoparticles display excellent antibacterial potential for the
Gram negative bacteria E. coli and
the Gram positive bacteria BCG [which serves as a surrogate for the
tuberculosis pathogen].
…In terms of anti-TB drug development,
this study suggests that NPs may represent useful candidates, but will require
significant development to ensure optimal bactericidal activity and low host
toxicity.”
-- Journal of Nanobiotechnology, May 2012, “Antibacterial
Activities of Gold and Silver Nanoparticles Against Escherichia coli and
bacillus Calmette-Guerin
Of related interest, a company called Klearsen Corporation apparently
at one point developed an inhalable lung treatment utilizing atomized particles
of ionic silver along with a small amount of peppermint oil.
The treatment was designed for tuberculosis, as well as for Mycopbacterium
Avium Complex (MAC), i.e., the cause of so-called “hot tub lung,” in which the
pathogens Mycobacterium avium or Mycobacterium abscessus infect the lungs
similar to the way the tuberculosis pathogen does.
According to a Klearsen Corporation spokesman in March 2006,
preliminary clinical studies had yielded some astonishing results:
"After
having very good results against Mycobacterium tuberculosis, it seemed like the
obvious step to screen the compound against M. avium and M. abscessus,"
said Steve Frank, the project director.
"We have
been utilizing this compound in our patented Respiratory Inhalation Therapy
treatment for years to deal with numerous ailments and this testing finally
provides us with the substantiation necessary to move into the mycobacteria
treatment arena."
Preliminary work
with an MAC (Mycobacterium avium complex) patient in clinical trials has shown
encouraging results and suggests that the treatment period for this condition
could be reduced from a typical 12- to 16-month course of antibiotics to a
4-week course of the Klearsen Respiratory Inhalation Therapy.
‘This is a very
exciting period of demonstration for our KC-287 antimicrobial compound,’ stated
Chris Groutt, the Marketing Director. ‘We
have all seen the dramatic capabilities of this product and now it is finally
reaching the surface where it can benefit huge portions of the population.’
The treatment utilizes a nebulized mist of KC-287 to repeatedly coat the inner surfaces of the lungs. Being on the air-side of the tissue and formulated to gain enhanced entry into the bacterial cells allow the active agent to very effectively kill the mycobacteria with very low total dose to the subject.
The treatment utilizes a nebulized mist of KC-287 to repeatedly coat the inner surfaces of the lungs. Being on the air-side of the tissue and formulated to gain enhanced entry into the bacterial cells allow the active agent to very effectively kill the mycobacteria with very low total dose to the subject.
Although the
treatment is still in the experimental stage, early results are so encouraging,
that clinical studies are moving forward.
Paul Whittle, the CEO of Klearsen Corp., is anxious to see this technology applied to MAC as well as tuberculosis patients:
Paul Whittle, the CEO of Klearsen Corp., is anxious to see this technology applied to MAC as well as tuberculosis patients:
‘Klearsen
Corporation holds several patents relating to the respiratory therapy and the
active agent. We are very pleased to see this level of performance in vivo.’”
While the above treatment was apparently patented by the Klearsen
Corporation, and as of 2006 the company was “still seeking FDA approval.” That approval was apparently never granted,
and the company website no longer exists.
Nevertheless, people from around the world are reporting
good effects after using colloidal silver for TB. As an example, according to an online health
board, colloidal silver is being used by individuals in Nigeria to help stem
the country’s growing problem with tuberculosis. As one individual wrote:
“When we first started offering colloidal silver in 2007, we were
approached by seven patients. Six were HIV positive and one had Tuberculosis. After
three months of taking colloidal silver the lady with the TB was clean. Her doctor
couldn’t believe it.”
Of course, anecdotal reports like that do not constitute “proof”
that colloidal silver is effective against the TB pathogen. But you can learn more about silver’s ability
to kill the TB pathogen by reading the following two articles and related
clinical study:
Learn
More About Colloidal Silver…
If you’d
like to learn more about colloidal silver and its remarkable ability to quite literally decimate
infectious microorganisms – even drug-resistant pathogens – then consider
taking a few moments to explore The Silver Edge
website, which is the world’s largest online repository of factual
information about colloidal silver.
For example:
- If you’d like to learn more about the astonishing, infection-fighting qualities of colloidal silver, see over 100 articles at this link.
- If you’d like to learn how hundreds of experienced colloidal silver users have cured their own infections and diseases with colloidal silver, see this link.
- If you’d like to learn how incredibly easy it is to make your own high-quality colloidal silver for less than 36 cents a quart, and see how it compares to conventional colloidal silver generators, see this link.
- If you’d like to learn why the Micro-Particle Colloidal Silver Generator is the world’s #1 best-selling colloidal silver generator, see this link.
- Finally, if you’d like to save a whopping $100 on a brand new Micro-Particle Colloidal Silver Generator, so you can make your own high-quality colloidal silver for less than 36 cents a quart and avoid those high mark-ups in health food stores, see this link.
Meanwhile, I’ll be back next week with another great article on
colloidal silver….
Yours for the safe, sane and responsible
use of colloidal silver,
Steve Barwick, author
The Ultimate Colloidal Silver Manual
The Ultimate Colloidal Silver Manual
Helpful Links:
Important Note and
Disclaimer: The contents of this Ezine have not been
evaluated by the Food and Drug Administration.
Information conveyed herein is from sources deemed to be accurate and
reliable, but no guarantee can be made in regards to the accuracy and
reliability thereof. The author, Steve
Barwick, is a natural health journalist with over 30 years of experience
writing professionally about natural health topics. He is not
a doctor. Therefore, nothing stated in
this Ezine should be construed as prescriptive in nature, nor is any part of
this Ezine meant to be considered a substitute for professional medical
advice. Nothing reported herein is
intended to diagnose, treat, cure or prevent any disease. The author is simply reporting in
journalistic fashion what he has learned during the past 17 years of
journalistic research into colloidal silver and its usage. Therefore, the information and data presented
should be considered for informational purposes only, and approached with
caution. Readers should verify for
themselves, and to their own satisfaction, from other knowledgeable sources
such as their doctor, the accuracy and reliability of all reports, ideas,
conclusions, comments and opinions stated herein. All important health care decisions should be
made under the guidance and direction of a legitimate, knowledgeable and
experienced health care professional.
Readers are solely responsible for their choices. The author and publisher disclaim
responsibility and/or liability for any loss or hardship that may be incurred
as a result of the use or application of any information included in this
Ezine.
Copyright
2016 | Life & Health Research Group, LLC | PO Box 1239 | Peoria AZ
85380-1239 | All rights reserved.
Posts
